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1. Introduction 
Inhibitors of peptidyl transferase studied so far 
have been mainly either antibiotics or structural 
analogues of part of the natural substrate. In this 
paper we present evidence that a different group of 
compounds, namely phenylboric acid and its deriva- 
tives, inhibits peptidyl transferase rather strongly. 
Phenylboric acid has been hitherto’known as a 
specific inhibitor of serine proteases [ 1 ] which acts 
as a transition-state analogue by forming a tetrahedral 
adduct with the serine -OH group and the histidine 
residue in the catalytic centre of these proteases [2]. 
Phenylboric acid also forms a complex with cis-diol 
groups, i.e., the 2’,3’-cis-diol group of ribose at the 
3’-terminus of RNA [3]. 
In this paper we describe the effect of phenylboric 
acid on the catalytic and binding properties of pep- 
tidy1 transferase of Escherichia coli ribosomes. 
2. Materials and methods 
2.1. Materials 
Puromycin dihydrochloride was obtained from 
Nutritional Biochemicals, USA. Phenylboric acid, 
o-nitrophenylboric acid, m-nitrophenylboric acid and 
m-aminophenylboric acid were gifts from Dr. A. Holy 
and Dr. I. Rosenberg of the Institute of Organic 
Chemistry and Biochemistry, Prague, and were pre- 
pared as in [4]. The 2’ (3’).O-(N-formylmethionyl)- 
adenosine-5’-phosphate (PA-fMet) was a gift from 
Dr. A. A. Krayevsky, Institute of Molecular Biology, 
Moscow. 
L-[4,5-3H] Leucine (55 Ci/mmol), L-[2,4,6-3H]- 
phenylalanine (73 Ci/mmol) and Lphenyl-[2,3-3H]- 
alanine (16 Cilmmol) were the products of the Radio- 
chemical Centre, Amersham. 
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2.2. Preparation of ribosomes 
Ribosomes from E. coli were prepared by washing 
with 0.5 M NH,+Cl as described elsewhere [5]. 
2.3. Preparation of substrates 
Preparation of ac-[jH]Phe-tRNA and CACCA-ac- 
[3H] Leu were described earlier [6]. CACCA- [3H]Phe 
was prepared according to Pestka [7]. 
2.4. Transfer assays 
Transfer assay with CACCAac- [3H] Leu and puro- 
mycin was carried out under the conditions of the 
fragment reaction described by Monro et al. [6]. The 
acylaminoacyl-puromycin formed was extracted 
according to Miskin et al. [8]. 
Poly(U)-directed transfer of ac-Phe-residue from 
ac-[3H]Phe-tRNA to puromycin was measured 
according to [5]. 
The transfer reaction with PA-Net and CACCA- 
[3H]Phe was assayed as in [9]. 
2.5. Binding of acceptor and donor substrates 
The binding of the acceptor substrate, CACCA- 
[3H]Phe, to the ribosomes was determined in the 
presence of 20% ethanol according to P&tka [7]. 
The binding of the donor substrate, CACCA-ac- 
[jH] Leu, to the ribosomes was examined by the 
method of Celma et al. [lo]. 
3. Results 
3.1. Inhibition of peptidyl transferase activity by 
phenylboric acid and its derivatives 
Phenylboric acid and substituted phenylboric acids 
inhibited the capacity of the peptidyl transferase to 
form a new peptide bond assayed in three systems of 
varying complexity: (i) the transfer of the ac-Phe- 
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Table 1 
The effect of phenylboric and m-nitrophenylboric acid on transfer reactions with 
various substrates 
Transfer system 
Donor substrate 
PBA m-NPBA Acylaminoacyl 
(mM) (mM) transfer 
Acceptor substrate 
(cpm) (%) 
ac-[“HIPhe-tRNA Puromycin _ _ 
5 _ 
10 - 
_ 3 
- 5 
- 10 
CACCAac-[ 3H] Leu Puromycin _ - 
3 _ 
6 - 
10 _ 
- 1.5 
_ 3 
p A-fMet CACCA-[ ‘H] Phe - _ 
5 - 
10 _ 
- 2.5 
- 5 
2845 100 
2361 83 
1993 70 
1903 67 
653 23 
175 6 
2450 100 
1078 44 
602 25 
198 8 
1122 46 
128 5 
2015 100 
1192 59 
743 37 
605 30 
263 13 
The transfer reaction was examined with: (a) ribosomes (50 pmol), ac-[3H]Phe-tRNA 
(2 pmol) and puromycin (50 nmol); (b) ribosomes (45 pmol), acj3H]Leu-penta- 
nucleotide (0.28 pmol) and puromycin (15 nmol); (c) ribosomes (110 pmol), pA-fMet 
(200 nmol) and CACCAj3H]Phe (2 pmol). PBA: phenylboricacid;m-NPBA: m-nitro- 
phenylboric acid 
residue from acPhe-tRNA to puromycin; (ii) the trans- 
fer of the ac-Leu-residue from CACCA-ac-Leu to puro- 
mycin in the fragment reaction and (iii) the transfer 
of the fMet-residue from pA-fh4et to the terminal 
acceptor fragment CACCA-Phe. It is evident from the 
mM 
data in table 1 that all three systems are inhibited by 
phenylboric acid and m-nitrophenylboric acid and that 
m-nitrophenylboric acid is a more potent inhibitor 
than phenylboric acid. 
Figure 1 shows the effects of different concentra- 
tions of the inhibitors on the peptidyl transferase 
activity assayed by the fragment reaction. Asinhibitors 
were tested phenylboric acid and its derivatives, 
o-nitrophenylboric acid, m-nitrophenylboric acid, 
m-aminophenylboric acid and boric acid. m-Nitro- 
phenylboric acid was the most effective inhibitor 
Fig.1. Inhibition of ribosomal peptidyl transferase activity 
by phenylboric acid, maminophenylboric acid, m-nitro- 
phenylboric acid, o-nitrophenylboric acid and boric acid. 
Ribosomes (45 pmol) were examined in the fragment reac- 
tion with ac-[3H]Leu-pentanucleotide (0.35 pmol) as donor 
substrate and puromycin (15 nmol) as the acceptor substrate. 
(%) ac-[ “Hlleucyl-puromycin formation (100% transfer was 
3320 cpm corresponding to 0.14 fmol acetylleucyl-puromycin 
min-* pmol ribosomes-I); (mM) concentration of inhibitors; 
(1) m-nitrophenylboric acid, (2) phenylboric acid, (3) 
maminophenylboric acid, (4) o-nitrophenylboric acid, (5) 
boric acid. 
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Fig.2. Time course of inhibition of peptidyl transferase activ- 
ity by maminophenylboric a id, o-nitrophenylboric acid and 
m-nitrophenylboric a id. The effect of inhibitors (2.5 mM) 
was examined in the fragment reaction with ribosomes 
(45 pmol), acj3H]Leu-pentanucleotide (0.28 pmol) and 
puromycin (15 nmol). (1) control, (2) m-aminophenylboric 
acid, (3) o-nitrophenylboric acid, (4) m-nitrophenylboric 
acid. 
1 2 5 10 
1 / [PM1 (mM-‘1 
Fig.3. Inhibition of the peptidyl transferase by m-nitro- Fig.4. Inhibition of peptidyl transferase by m-nitrophenyl- 
phenylboric acid at different concentrations of puromycin. boric acid at different concentrations of CACCAac-[3H]Leu. 
The peptidyl transferase activity was determined in the frag- Peptidyl transferase activity was determined in fragment reac 
ment reaction with 55 pmol ribosomes, 0.33 pmol ac-[3H]- tion with 59 pmol niosomes, 50 nmol puromycin and 0.1, 
Leu-pentanucleotide and 1,0.5,0.2 and 0.1 mM puromycin. 0.25 and 0.5 pmol CACCAac-[ ‘H] Leu; Y is expressed as 
Y is expressed as fmol acetylleucyl-puromycin formed min-’ fmol acetylleucyl-puromycin formed min-’ pm01 riiosomes-‘. 
pmol ribosomes-I. The concentrations of m-nitrophenylboric The concentrations of m-nitrophenylboric acid: (1) control, 
acid: (1) control, (2) 1 mM, (3) 1.3 mM. (2) 1 mM, (3) 2 mM. 
reaching 50% inhibition at 1 mM’, phenylboric acid, 
o-nitrophenylboric acid and m-aminophenylboric 
acid inhibited the fragment reaction to 50% al about 
a 3 mM concentration. The least inhibitory effect was 
observed for boric acid that did not reach 50% inhibi- 
tion even at the 7 mM concentration. The effect of 
substituted phenylboric acids on the time course of 
the fragment reaction is illustrated in fig.2. Also here 
m-nitrophenylboric acid showed the highest inhibitory 
effect. 
3.2. Competition of m-nitrophenylboric acid with 
substrates of the peptiyl transferase 
The Lineweaver-Burk plot of inhibition of the 
fragment reaction by m-nitrophenylboric acid at dif- 
ferent concentrations of puromycin indicates that the 
inhibitor competes with puromycin for the binding 
site (fig.3). Ki for m-nitrophenylboric acid is 4.6 X 
104. 
On the other hand, inhibition of the peptidyl trans- 
ferase activity by m-nitrophenylboric acid is non- 
competitive with respect to the donor substrate, as 
shown by Lineweaver-Burk plot in fig.4. 
l/ KACCA-ac(3H)Leul ( nM’1 
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3.3. Effect of substituted phenylboric acids on the 
binding of the donor and acceptor substrates to 
ribosomes 
A direct analysis of the effect of substituted phenyl- 
boric acids on the binding of the donor and acceptor 
substrates indicates that these compounds specifically 
inhibit the binding of the acceptor substrate, CACCA- 
Phe, to the-acceptor binding site. The interaction of 
the donor substrate, CACCA-a&%, with peptidyl 
transferase donor site is not affected to any significant 
degree (table 2). The inhibitory effect with regard to 
the acceptor site increases in the order: boric acid < 
m-aminophenylboric a id 5 phenylboric acid < 
o-nitrophenylboric acid < m-nitrophenylboric acid. 
Further evidence for an action of phenylbo~c acid 
on binding of the acceptor substrate comes from a 
kinetic study of inhibition of the binding of CACCA- 
Phe to ribosomes. The results presented in fig.5 as a 
double reciprocal plot indicate that phenylboric acid 
competitively inhibits the binding of the acceptor 
substrate. Ki for phenylboric acid is 5.2 X 104. 
4. Discussion 
Phenyibo~c acid and its derivatives inhibit the 
peptidyl transferase by competing with the binding of 
the acceptor substrate. The decrease of peptide bond 
formation corresponds to the loss of binding capacity 
of the acceptor substrate. On the other hand, the bind- 
ing of the donor substrate remains almost unaffected. 
A similar change in catalytic and binding properties 
Table 2 
The effect of phenylboric acid, ~~inoph~ylboric acid, m-nitrophenylboric acid, 
o~i~ophenylbor~ acid and boric acid on the bindii of CACCA-(3H]Phe and 
CACCA-ac-]‘H]Leu to ribosomes 
Inhibitor Concentration CACCA-[ 3H]Phe CACCA-ac-[sH]Leu 
(mM) @pm) (%) &pm) (%) 
Phenylboric acid 
m-tiophenylboric 
acid 
m-Nitrophenylboric 
acid 
o-Nitrophenylboric 
acid 
Boric acid 
- 3620 
0.5 2020 
1 1430 
5 750 
9 
100 
56 
40 
21 
0.5 2110 
1 1550 
5 890 
9 
59 
43 
24 
OS 250 
1 120 
5 
9 
7 
3 
0.5 1070 
1 490 
5 260 
9 
30 
14 
I 
5 2497 69 
10 2101 58 
1515 
1439 
1320 
1318 88 
1454 96 
1394 92 
1212 80 
1320 88 
1409 93 
100 
95 
88 
The binding of acceptor substrate was examined with ribosomes (140 pmol) and 
CACCA-[‘HIPhe (0.4 pmol); 100% binding (3620 cpm) corresponded to 25% of 
CACCAj3H]Phe added to the reaction mixture. The binding of donor substrate was 
examined with ribosomes (140 pmol) and CACCA-ac-[‘H]L.eu (0.33 pmol); 100% 
bindii corresponded to 19% of CACCAWZ-[~H)L~U added to the reaction mixture 
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Fig.5 Inhibition of binding of CACCA-j3H]Phe to ribosomes 
by phenylboric acid at different concentrations of [ sH]Phe- 
pentanucleotide. Binding was determined with 106 pmol 
ribosomes and 0.36,0.54 and 0.81 pmol [‘HlPhe-penta- 
nucleotide; Y is expressed-as fmol ~s~]~e~e~t~ucleotide 
bound min-’ pmol ribosomes-‘. The concentrations of
phenylboric acid: (1) control, (2) 0.3 mM, (3) I mM. 
was observed previously after treatment of ribosomes 
using procedures known to modify histidine in pro- 
teins with a high degree of specificity. Photooxida- 
tion in the presence of the sensitizing dye, which 
modifies histidine [I 1 J, results in inactivation of pep- 
tidy1 transferase [ 12,131; treatment with ethoxyformic 
anhydride that acylates accessible histidine residues 
under specific conditions 1141, abolishes peptidyl 
transferase activity of ribosomes f 151. Both these 
treatments affect not only peptide bond formation, 
but also the binding of acceptor substrate without 
altering the properties of the donor site [ 16,171, 
On the basis of these observations and also in regard 
of the known mode of action of phenylboric acids on 
se&e proteases [I ] f we are inchned to believe that a 
histidine residue, localized in the acceptor site of the 
peptidyl transferase, is involved both in the binding 
of the acceptor substrate and in peptide bond forma- 
tion. By analogy with the proteolytic enzymes, phenyl- 
boric acid might be considered as a transition-state 
analogue for peptidyt ransferase, which binds to its 
acceptor site by forming a complex with an OH-group 
(of protein or RNA) and a histidine residue localized 
at that site (fig.(i). By forming this complex, phenyl- 
boric acid prevents the access of the acceptor sub- 
strate to the acceptor site of the peptidyl transferase, 
The other alternative, that phenylboric acid inhibits 
the acceptor site of peptidyl transferase by forming a 
complex with the cis-diol group of the 3’-terminal 
ribose of 5 S RNA or 23 S RNA, localized incidentally 
in close vicinity of the acceptor site, seems less prob- 
able. 
The substituent groups, which withdraw electrons 
from the boron atom of phenylboric acid, strengthen 
both the B-N and B-Q interaction and also the stabil- 
ity of the tetrahedral dduct. The ~~ibito~ effect of 
substituted-phenylbo~c acids on peptidyl transferase 
increases in the expected sequence: m-amino- = H- < 
o-&o- < m-nitro-. A similar effect of substituents 
was found in studies on inhibition of serine proteases 
by phenylboric acids [2]. This observation isalso in 
agreement with the proposed rn~h~~rn of inhibi- 
tion of peptidyl transferase by phenylboric acids. 
A comparison of the effect of antibiotics or sub- 
strate analogues on peptidyl transferase and the 
action of phenylboric acids reveals that the effect of 
phenylboric acid is very similar to that of chloram- 
phenicol . Both compounds inhibit specifically the 
binding of the acceptar substrate without affecting 
the donor site [18}. The analogy with sparsomycin 
and gougerotin is less pronounced, because these anti- 
biotics also inhibit the binding of the acceptor sub- 
strate, but ~rn~~eou~y stimulate the binding of 
the donor substrate fig]. 
Our interpretation of an interaction of phenyl- 
boric acid with a histidine residue localized in the 
acceptor site of the peptidyl transferase is in agree- 
ment with the following reports: Baxter and Z&d 
I151 found that ~act~~ation f the peptidyl trans- 
ferase with ethoxyformic ~yd~de was due to its 
reaction with a histidine residue in ribosamal protein 
L16. Protein L16 was shown to be a,constituent of
the acceptor site of the peptidyl transferase both by 
dependence of the binding of chloramphenicol to the 
50 S subunit on the presence of L16 f 191 and by 
affinity labelling [20,21]. With the use of reconstitu- 
RIBOSOME 
A SITE 
His RIWXOME 
A SITE 
Fig.6. A tentative model of the tetrahedral dduct of phenyl- 
boric acid with the active Centre of peptidyl tmnsferase. 
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tion of the 50 S ribosomal subunit Dohme and 
Fsbnestock [22] demonstrated that ribosomal pro- 
teins L2, L16 and L4 were the major targets identified 
for inactivation of the peptidyl trausferase during 
photochemical modification of 50 S ribosomal sub- 
units of E. coli. 
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